About
Sortina Pharma develops small molecule therapeutics targeting sortilin, focusing on treatment of serious diseases such as cancer, including glioblastoma multiforme, and neurodegenerative disorders.
Explore Sortina Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.